Company news
Rznomics Inc. news in 2026
Rznomics Inc.'s news releases, calls and decks from 2026, newest first.
Rznomics Reports Major Advances in High-Efficiency Circular RNA Production in Nucleic Acids Research
September 5, 2026
Rznomics Joins Lilly Gateway Labs in San Diego to Accelerate RNA Therapeutics
August 23, 2026
Rznomics Announces U.S. FDA Regenerative Medicine Advanced Therapy Designation Granted to 'RZ-001' for Hepatocellular Carcinoma
May 8, 2026
Rznomics Reports Interim Clinical Data for RZ-001 in Hepatocellular Carcinoma at AACR 2026 Demonstrating Encouraging Efficacy and Favorable Safety Profile
April 20, 2026